Preparing for success in modernizing the science behind the development and regulation of medical products
ACDRS 2023 Session 3 - Learning and Confirming Trials: Finding and Confirming the Right Dose
Date:
Wednesday, April 26, 2023 - 8:30 am to Friday, April 28, 2023 - 4:00 am
Location:
UCDC, 1st floor meeting room
1608 Rhode Island Ave NW, Washington DC
This is Session 3 of 6. Must register for the entire 2023 Course and not per session.
Session Co-Chairpersons:
Diane K. Jorkasky, MD FACP, Consultant to Pharma
Michael J. Fossler, PharmD PhD, Executive Consultant/Vice-President, Strategic Consulting, Cytel
Lecturers
| Theodore Danoff, MD PhD | Chief Medical Officer, Pathalys Pharma, Inc. |
| Dennis Fisher, MD | Principal, The “P Less Than” Company |
|
Michael J. Fossler, PharmD PhD |
Vice President, Quantitative Sciences, Trevena |
| Christine Garnett, PharmD | Lead, Interdisciplinary Team for Cardiac Safety Studies and Clinical Analyst, Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration |
| Charlie T. Gombar, PhD | ACDRS Director |
| Eric A. Hughes, MD PhD | Executive Vice President R&D and Chief Medical Officer, Teva |
|
Diane K. Jorkasky, MD FACP |
Consultant to Pharma |
| Steven Shafer, MD | Professor Emeritus, Anesthesiology, Perioperative and Pain Medicine, Stanford University |
| Brian Smith, PhD | Executive Director, Biostatistics, Novartis |
| Dominic G. Spinella, PhD | Co-Founder and Partner, Translational Medicine Partners, Inc. |
| Stacey Tannenbaum, PhD FISoP | Senior Director, Pharmacometrics US, Clinical Pharmacology and Exploratory Development, Astellas Pharma |
Additional faculty - case study proctors
| Dustin Little, MD | Global Clinical Lead, Nephrology, AstraZeneca |
| others to be confirmed |